Avextra is a pharmaceutical manufacturing industry.
Avextra has raised $6.8M in total funding. The most recent round was Grant. The last funding was announced in December 2024.
Avextra's investors include Iberis Capital, European Union.
Avextra is headquartered in Bensheim, Germany.
Avextra is a pharmaceutical manufacturing industry.
Avextra is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avextra — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/avextra. Accessed October 29, 2026.
VCBacked. (2024). Avextra — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/avextra
{{cite web |title=Avextra — Funding & Investors |url=https://www.vcbacked.co/company/avextra |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated